7-86844997-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000840.3(GRM3):​c.2391+5092T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.646 in 151,908 control chromosomes in the GnomAD database, including 34,295 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.65 ( 34295 hom., cov: 31)

Consequence

GRM3
NM_000840.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.976

Publications

13 publications found
Variant links:
Genes affected
GRM3 (HGNC:4595): (glutamate metabotropic receptor 3) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000840.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.9 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000840.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM3
NM_000840.3
MANE Select
c.2391+5092T>C
intron
N/ANP_000831.2
GRM3
NM_001363522.2
c.1325-5373T>C
intron
N/ANP_001350451.1Q14832-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM3
ENST00000361669.7
TSL:1 MANE Select
c.2391+5092T>C
intron
N/AENSP00000355316.2Q14832-1
GRM3
ENST00000439827.1
TSL:1
c.1325-5373T>C
intron
N/AENSP00000398767.1Q14832-2
GRM3
ENST00000953115.1
c.2391+5092T>C
intron
N/AENSP00000623174.1

Frequencies

GnomAD3 genomes
AF:
0.645
AC:
97968
AN:
151790
Hom.:
34240
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.908
Gnomad AMI
AF:
0.512
Gnomad AMR
AF:
0.484
Gnomad ASJ
AF:
0.514
Gnomad EAS
AF:
0.244
Gnomad SAS
AF:
0.321
Gnomad FIN
AF:
0.630
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.588
Gnomad OTH
AF:
0.607
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.646
AC:
98079
AN:
151908
Hom.:
34295
Cov.:
31
AF XY:
0.637
AC XY:
47269
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.908
AC:
37662
AN:
41472
American (AMR)
AF:
0.484
AC:
7383
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.514
AC:
1779
AN:
3462
East Asian (EAS)
AF:
0.245
AC:
1259
AN:
5144
South Asian (SAS)
AF:
0.322
AC:
1551
AN:
4822
European-Finnish (FIN)
AF:
0.630
AC:
6641
AN:
10542
Middle Eastern (MID)
AF:
0.575
AC:
169
AN:
294
European-Non Finnish (NFE)
AF:
0.588
AC:
39904
AN:
67896
Other (OTH)
AF:
0.601
AC:
1266
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1514
3028
4542
6056
7570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
746
1492
2238
2984
3730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.791
Hom.:
10442
Bravo
AF:
0.647
Asia WGS
AF:
0.362
AC:
1261
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
1.1
DANN
Benign
0.68
PhyloP100
-0.98
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1989796;
hg19: chr7-86474313;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.